Specialty Drug Pipeline Reviews to help you
Control Medical Drug Spend

Sign up for RJ Health Drug Alerts below to access our collection of reviews.

If you are already a Drug Alerts subscriber, simply re-enter your email to be redirected.

Our current collection of specialty drug pipeline reviews available to Drug Alerts subscribers includes:

Tildrakizumab
2018 Drug Pipeline Review
PDUFA: March 26, 2018

Ibalizumab-uiyk (Trogarzo™) Biologic
2018 Drug Pipeline Review
PDUFA: April 3, 2018

Burosumab
2018 Drug Pipeline Review
PDUFA: April 17, 2018

Herceptin (Trastuzumab) Biosimilars
2018 Drug Pipeline Review
PDUFA: April 30, 2018

Erenumab
2018 Drug Pipeline Review
PDUFA: May 17, 2018

Rituxan (Rituximab) Biosimilars
2018 Drug Pipeline Review
PDUFA: July 12, 2018

Patisiran
2018 Drug Pipeline Review
PDUFA: August 11, 2018

Lanadelumab
2018 Drug Pipeline Review
PDUFA: August 28, 2018

Volanesorsen Sodium
2018 Drug Pipeline Review
PDUFA: August 30, 2018

Moxetumomab pasudotox
2018 Drug Pipeline Review
PDUFA: September 9, 2018